Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1031: At what point in time is the population assessed for the calculation of the Crude Death Rate?

A. 1st January
B. 1st May
C. 1st July (Correct Answer)
D. 31st December

Explanation: ### Explanation **1. Why 1st July is Correct:** The **Crude Death Rate (CDR)** is defined as the number of deaths per 1,000 population in a given year. To calculate this accurately, the denominator must represent the average population exposed to the risk of death throughout that year. In demography and vital statistics, the **Mid-year Population** (as of July 1st) is used as the standard estimate for the average population. This accounts for births, deaths, and migrations occurring during the first and second halves of the year, providing a statistically stable denominator. **2. Why Other Options are Incorrect:** * **1st January (Option A):** This represents the population at the start of the year. It does not account for the growth or changes that occur during the subsequent 12 months. * **1st May (Option B):** This date holds no specific demographic significance for annual rate calculations. * **31st December (Option D):** This represents the population at the end of the year. Using this would overestimate the denominator if the population is growing, thereby artificially lowering the calculated death rate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Formula:** $CDR = \frac{\text{Number of deaths during the year}}{\text{Mid-year population}} \times 1000$. * **Mid-year Population:** It is the standard denominator for almost all annual vital indices, including Crude Birth Rate (CBR) and General Fertility Rate (GFR). * **Limitation:** The CDR is "crude" because it does not take into account the **age and sex composition** of the population. * **Comparison:** To compare mortality between two different populations (e.g., Kerala vs. UP), **Age-Standardized Death Rates** are the preferred indicator, not CDR.

Question 1032: In a case-control study, what is its most characteristic feature?

A. Odds ratio estimation (Correct Answer)
B. Problem bias
C. Yield incidence rate
D. Expensive

Explanation: ### Explanation In epidemiology, a **Case-Control Study** is a retrospective, observational study design that starts with the outcome (disease) and looks backward to identify exposures. **Why "Odds Ratio Estimation" is Correct:** The hallmark of a case-control study is that it begins with people who already have the disease (Cases) and compares them to those who do not (Controls). Because the researcher determines the number of cases and controls at the start, the true **Incidence** (new cases in a population at risk) cannot be calculated. Instead, we calculate the **Odds Ratio (OR)**, which estimates the strength of the association between an exposure and an outcome. It is the only measure of association possible in this study design. **Analysis of Incorrect Options:** * **B. Problem Bias:** While case-control studies are highly prone to biases (especially **Recall Bias** and **Selection Bias**), bias is a limitation or a flaw, not a "characteristic feature" or a goal of the study design. * **C. Yield Incidence Rate:** This is incorrect. Incidence can only be calculated in **Cohort Studies**, where a healthy population is followed forward in time to see who develops the disease. * **D. Expensive:** Case-control studies are actually **inexpensive** and quick compared to cohort studies, as they do not require long-term follow-up. **High-Yield Clinical Pearls for NEET-PG:** * **Direction of Study:** Retrospective (Proceeds from Effect to Cause). * **Best For:** Rare diseases or diseases with long latency periods. * **Matching:** A technique used in case-control studies to eliminate the effects of **Confounding variables**. * **Formula for OR:** (ad / bc) or (Odds of exposure among cases / Odds of exposure among controls).

Question 1033: The biological transmission of filariasis is an example of which type of transmission?

A. Propagative transmission
B. Cyclical transmission
C. Cyclo-developmental transmission (Correct Answer)
D. Cyclo-propagative transmission

Explanation: **Explanation:** Biological transmission occurs when an infectious agent undergoes development, multiplication, or both within an arthropod vector before being transmitted to a human host. **Why Cyclo-developmental transmission is correct:** In **Filariasis** (caused by *Wuchereria bancrofti*), the microfilariae ingested by the mosquito undergo essential developmental stages (L1 to L3 larvae) but **do not multiply** in number. Since there is a change in form (cycle) without an increase in number (propagation), it is classified as cyclo-developmental transmission. Another classic example is **Guinea worm** (*Dracunculus medinensis*) in Cyclops. **Analysis of Incorrect Options:** * **Propagative transmission:** The agent multiplies in number but undergoes no change in form. Examples: **Plague** (Yersinia pestis in rat fleas). * **Cyclo-propagative transmission:** The agent undergoes both developmental changes and multiplication. Examples: **Malaria** (*Plasmodium* in Anopheles) and **Kala-azar** (*Leishmania* in sandflies). * **Cyclical transmission:** This is a general term indicating that the parasite undergoes a cycle in the vector, but it is less specific than "cyclo-developmental" for this question. **High-Yield Clinical Pearls for NEET-PG:** * **Extrinsic Incubation Period:** The time required for the parasite to complete its development/multiplication inside the vector before it becomes infective. * **Mechanical Transmission:** The vector simply carries the pathogen externally (e.g., Housefly carrying Typhoid) without any biological interaction. * **Transovarial Transmission:** When the pathogen is passed from the adult vector to its offspring (e.g., **Scrub Typhus** in mites, **Yellow Fever** in mosquitoes).

Question 1034: Which of the following is NOT a risk factor for head and neck cancers?

A. Alcohol consumption
B. Smoking
C. Tobacco use
D. Unflourinated water (Correct Answer)

Explanation: **Explanation:** Head and neck cancers (HNCs) are primarily associated with lifestyle-related carcinogens and viral infections. Understanding the distinction between established risk factors and unrelated environmental factors is crucial for NEET-PG. **Why "Unfluorinated water" is the correct answer:** There is no scientific evidence linking the absence (or presence) of fluoride in water to the development of head and neck cancers. Fluoridation of water is a public health measure intended to prevent dental caries. While excessive fluoride can lead to dental or skeletal fluorosis, it is not classified as a carcinogen for the mucosal linings of the upper aerodigestive tract. **Analysis of incorrect options:** * **Tobacco use (C) and Smoking (B):** These are the most significant risk factors for HNCs. Tobacco contains potent carcinogens like nitrosamines and polycyclic aromatic hydrocarbons that cause DNA damage in the squamous epithelium. * **Alcohol consumption (A):** Alcohol acts as a solvent, enhancing the penetration of tobacco carcinogens into the mucosal cells. It also metabolizes into acetaldehyde, a known carcinogen. When combined with tobacco, alcohol has a **synergistic (multiplicative) effect** on cancer risk. **High-Yield Clinical Pearls for NEET-PG:** * **Most common histological type:** Squamous Cell Carcinoma (>90%). * **Emerging Risk Factor:** Human Papillomavirus (**HPV-16**) is now a major cause of oropharyngeal cancers, especially in non-smokers. * **Epstein-Barr Virus (EBV):** Specifically associated with Nasopharyngeal Carcinoma. * **Dietary Factors:** Deficiencies in Vitamin A and C are linked to increased risk, while "Plummer-Vinson Syndrome" (iron deficiency anemia) is a precursor for post-cricoid carcinoma.

Question 1035: More false positive cases in a community signifies that the disease has:

A. High prevalence
B. High sensitivity
C. Low prevalence (Correct Answer)
D. Low sensitivity

Explanation: ### Explanation The number of false positives in a screening program is primarily influenced by the **Positive Predictive Value (PPV)** of the test, which is directly dependent on the **prevalence** of the disease in the population. **Why Low Prevalence is Correct:** PPV is the probability that a person with a positive test result actually has the disease. As the prevalence of a disease decreases, the PPV also decreases. In a low-prevalence setting, the vast majority of the population is healthy (true negatives). Even a highly specific test will encounter many healthy individuals, and a small percentage of "false alarms" across a large healthy population will eventually outnumber the few true cases. Therefore, in a community where a disease is rare, a positive test result is more likely to be a **false positive** than a true positive. **Analysis of Incorrect Options:** * **High Prevalence:** In this scenario, the PPV increases. Most positive results will be true positives because there are many diseased individuals to be found. * **High Sensitivity:** Sensitivity relates to the test's ability to identify true cases (reducing false negatives). It does not directly determine the number of false positives; that is the role of **Specificity**. * **Low Sensitivity:** This would lead to more **false negatives** (missing people who actually have the disease), not false positives. **High-Yield Clinical Pearls for NEET-PG:** * **Prevalence vs. Predictive Value:** PPV is directly proportional to prevalence; Negative Predictive Value (NPV) is inversely proportional to prevalence. * **Sensitivity and Specificity:** These are inherent properties of the test and **do not change** with disease prevalence. * **Screening Strategy:** To minimize false positives in a low-prevalence community, clinicians should use a test with very **high specificity**. * **Formula:** $PPV = \frac{\text{True Positives}}{\text{True Positives} + \text{False Positives}}$

Question 1036: What type of transmission is involved in the case of plague in rat flea?

A. Propagative (Correct Answer)
B. Cyclopropagative
C. Cyclo-developmental
D. None

Explanation: ### Explanation In vector-borne diseases, biological transmission occurs when the pathogen undergoes a necessary period of development or multiplication within the vector. This is categorized into three types based on how the pathogen behaves: **1. Why Propagative is Correct:** In **Propagative transmission**, the pathogen simply **multiplies** (increases in number) within the vector but undergoes **no change in form or morphology**. In the case of Plague (*Yersinia pestis*), the bacteria multiply extensively in the proventriculus of the rat flea (*Xenopsylla cheopis*), eventually causing a physical blockage. When the "blocked flea" attempts to feed, it regurgitates the multiplied bacteria into the host. Since the bacteria only increase in number without changing their biological stage, it is purely propagative. **2. Analysis of Incorrect Options:** * **Cyclo-developmental:** The pathogen undergoes **morphological change** (developmental stages) but **does not multiply**. * *Example:* Filarial parasite (*Wuchereria bancrofti*) in the mosquito. * **Cyclopropagative:** The pathogen undergoes **both** morphological change and an increase in number. * *Example:* Malaria parasite (*Plasmodium*) in the Anopheles mosquito. **3. NEET-PG High-Yield Pearls:** * **Plague Vector:** *Xenopsylla cheopis* (Rat flea) is the most efficient vector. * **Blockage Phenomenon:** This is the hallmark of plague transmission where the bacterial mass prevents blood from entering the flea's stomach, making the flea "hungry" and aggressive. * **Other Propagative Examples:** Yellow fever virus in mosquitoes and Arboviruses in general. * **Extrinsic Incubation Period:** The time required for the pathogen to develop/multiply in the vector before it becomes infective.

Question 1037: According to the American Heart Association & World Heart Federation 2015 criteria, low risk for acute rheumatic fever is defined as an incidence of less than which of the following per 100,000 school-aged children per year?

A. 1
B. 2 (Correct Answer)
C. 0.1
D. 0.01

Explanation: ### Explanation The classification of populations into "low risk" or "moderate-to-high risk" for Acute Rheumatic Fever (ARF) is crucial because the diagnostic criteria (Jones Criteria) differ based on this risk profile. **1. Why Option B is Correct:** According to the **2015 Revised Jones Criteria** (endorsed by the American Heart Association and the World Heart Federation), a population is defined as **low risk** if: * The incidence of ARF is **< 2 per 100,000 school-aged children (ages 5–14 years)** per year, **OR** * The prevalence of Rheumatic Heart Disease (RHD) is **≤ 1 per 1,000 population** per year (at any age). In low-risk populations, the diagnostic criteria are stricter to avoid overdiagnosis. In moderate-to-high risk populations (incidence ≥ 2 per 100,000), the criteria are expanded (e.g., monoarthritis and polyarthralgia are accepted as major and minor criteria, respectively). **2. Why Other Options are Incorrect:** * **Option A (1):** While 1 per 1,000 is the threshold for RHD prevalence, it is not the threshold for ARF incidence. * **Options C & D (0.1 and 0.01):** These values are far too low. While developed nations have seen a massive decline in ARF, the standardized epidemiological cutoff remains at 2 per 100,000. **3. High-Yield NEET-PG Pearls:** * **Jones Criteria 2015 Update:** The most significant change was the stratification of criteria based on risk (Low vs. Moderate/High). * **Major Criteria for Low Risk:** Carditis (clinical or subclinical), Polyarthritis, Chorea, Erythema marginatum, and Subcutaneous nodules. * **Major Criteria for Moderate/High Risk:** Includes the above, but also accepts **Monoarthritis** or **Polyarthralgia**. * **Subclinical Carditis:** Echocardiographic evidence of valvulitis is now considered a "Major" criterion even if a murmur is absent (in all risk groups). * **India's Status:** India is considered a **Moderate-to-High risk** zone for ARF/RHD.

Question 1038: What is the period of communicability of Tetanus?

A. 7 days
B. None (Correct Answer)
C. 21 days
D. 14 days

Explanation: **Explanation:** The correct answer is **None** because Tetanus is a **non-communicable disease**. Unlike many other infectious diseases, Tetanus is not transmitted from person to person. **Why "None" is correct:** Tetanus is caused by the neurotoxin produced by *Clostridium tetani*. The infection is acquired through environmental exposure—specifically, the introduction of spores into contaminated wounds (soil, street dust, or animal feces). Since the bacteria do not spread from one individual to another through respiratory droplets, bodily fluids, or physical contact, there is no "period of communicability." **Why other options are incorrect:** * **7, 14, and 21 days:** These timeframes are often associated with the **incubation period** of Tetanus (which typically ranges from 3 to 21 days, with an average of 10 days). However, the incubation period refers to the time between infection and the onset of symptoms, not the ability to spread the disease. Students often confuse these two concepts in exam settings. **High-Yield NEET-PG Pearls:** * **Reservoir:** The primary reservoir is the intestine of animals (horses, cattle, dogs) and humans, where the organism lives as a harmless commensal. * **Mode of Transmission:** Infection occurs via contaminated wounds, burn injuries, or unsterile surgical procedures (e.g., neonatal tetanus via an infected umbilical stump). * **Herd Immunity:** Tetanus is the only vaccine-preventable disease for which **herd immunity does not exist**, as the protection is purely individual and the source of infection is environmental. * **Clinical Sign:** The "Rule of 7" (Neonatal Tetanus) – symptoms typically appear on the 7th day of life in a previously healthy baby who loses the ability to suck.

Question 1039: Post exposure, Measles vaccine must be given within how many days?

A. 3-4 days (Correct Answer)
B. 10 days
C. 10-14 days
D. 1-6 months

Explanation: **Explanation:** The correct answer is **A. 3-4 days**. **1. Why 3-4 days is correct:** Measles has an incubation period of approximately 10–14 days. When a susceptible individual is exposed to the virus, the Measles vaccine can provide **post-exposure prophylaxis (PEP)** if administered within **72 hours (3 days)** of exposure. Some guidelines extend this window up to 4 days. The vaccine induces an immune response faster than the natural progression of the virus, effectively preventing or significantly modifying the severity of the disease. **2. Why the other options are incorrect:** * **B & C (10–14 days):** This is the typical **incubation period** of Measles. By this time, the virus has already replicated extensively, and clinical symptoms (prodrome/rash) begin to appear. Vaccination at this stage is ineffective as PEP. * **D (1-6 months):** This timeframe is irrelevant for PEP. However, it is worth noting that **Human Normal Immunoglobulin (Ig)** can be given up to 6 days post-exposure for those who cannot receive the live vaccine (e.g., infants <6 months or pregnant women). **3. High-Yield Clinical Pearls for NEET-PG:** * **Vaccine vs. Immunoglobulin:** If the 72-hour window for the vaccine is missed, Immunoglobulin can be administered within **6 days** of exposure to prevent or attenuate the disease. * **Minimum Age for PEP:** The Measles vaccine can be given as PEP to infants as young as **6 months**. However, this "zero dose" does not count toward the routine schedule; they must still receive the scheduled doses at 9 and 15 months. * **Type of Vaccine:** Measles is a **Live Attenuated Vaccine** (Edmonston-Zagreb strain in India). * **Infectivity:** Measles is most infectious during the **prodromal stage** (4 days before to 4 days after the appearance of the rash).

Question 1040: An epidemiological hypothesis should specify which of the following except?

A. Population
B. Time response relationship
C. Geographical trends (Correct Answer)
D. Expected outcome

Explanation: ### Explanation In epidemiology, a **hypothesis** is a tentative explanation for an observation or a scientific problem that can be tested by further investigation. To be scientifically valid and testable, an epidemiological hypothesis must be specific and clearly defined. **Why "Geographical Trends" is the correct answer:** While a hypothesis must specify the **location** (place) where the event occurs, it does not need to specify "geographical trends." Trends refer to the change in frequency or distribution over time across different areas, which is usually a **result** of descriptive studies rather than a component of the initial hypothesis itself. **Analysis of other options:** * **Population (A):** A hypothesis must define the specific group of people (e.g., age, sex, occupation) who are at risk or being studied. * **Time-response relationship (B):** This refers to the temporal association (e.g., the incubation period or the duration of exposure required to produce the effect). A hypothesis must specify when the exposure occurred and when the outcome is expected. * **Expected outcome (D):** The hypothesis must clearly state the disease or health condition being studied (the dependent variable). **High-Yield NEET-PG Pearls:** 1. **Components of a Good Hypothesis:** Often remembered by the variables of Descriptive Epidemiology: **Person** (Population), **Place** (Location), **Time** (Time-response), and **Effect** (Expected outcome/Disease). 2. **Criteria for a Hypothesis:** It must be: * Testable * Specific (not vague) * Based on existing knowledge * State the cause-and-effect relationship. 3. **Null Hypothesis ($H_0$):** States there is no difference between groups; researchers aim to reject this to prove their study hypothesis ($H_1$).

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free